Which has higher earnings & valuation, HIT or OPRX?

OptimizeRx has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health In Tech $32.83M 1.74 -$4.59M -$0.07 N/A OptimizeRx $109.43M 1.26 $5.13M $0.23 31.70

Which has higher earnings & valuation, CCLD or HIT?

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.77 $10.80M $0.07 31.00 Health In Tech $32.83M 1.74 -$4.59M -$0.07 N/A

Health In Tech (HIT) Competitors

$0.87 +0.06 (+7.54%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.85 -0.02 (-2.77%)

As of 09/18/2026 07:30 PM Eastern

Compare

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

Should you buy Health In Tech stock or one of its competitors? Health In Tech's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and CareCloud (CCLD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Health In Tech compare to American Well?

Health In Tech (NASDAQ:HIT) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Health In Tech presently has a consensus price target of $3.50, indicating a potential upside of 301.79%. American Well has a consensus price target of $9.50, indicating a potential downside of 30.43%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Health In Tech has higher earnings, but lower revenue than American Well. Health In Tech is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.74	-$4.59M	-$0.07	N/A
American Well	$249.32M	0.91	-$95.70M	-$4.77	N/A

Health In Tech has a net margin of 0.00% compared to American Well's net margin of -35.75%. Health In Tech's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
American Well	-35.75%	-30.12%	-22.30%

56.1% of American Well shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, American Well had 2 more articles in the media than Health In Tech. MarketBeat recorded 2 mentions for American Well and 0 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.84 beat American Well's score of 0.76 indicating that Health In Tech is being referred to more favorably in the media.

Company	Overall Sentiment
Health In Tech	Very Positive
American Well	Positive

Health In Tech has a beta of 2.72, meaning that its share price is 172% more volatile than the broader market. Comparatively, American Well has a beta of 1.71, meaning that its share price is 71% more volatile than the broader market.

Summary

Health In Tech beats American Well on 12 of the 16 factors compared between the two stocks.

How does Health In Tech compare to OptimizeRx?

Health In Tech (NASDAQ:HIT) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

76.5% of OptimizeRx shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

OptimizeRx has a net margin of 4.66% compared to Health In Tech's net margin of 0.00%. OptimizeRx's return on equity of 9.44% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
OptimizeRx	4.66%	9.44%	7.11%

OptimizeRx has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.74	-$4.59M	-$0.07	N/A
OptimizeRx	$109.43M	1.26	$5.13M	$0.23	31.70

Health In Tech has a beta of 2.72, meaning that its stock price is 172% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

In the previous week, OptimizeRx had 3 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for OptimizeRx and 0 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.84 beat OptimizeRx's score of 0.94 indicating that Health In Tech is being referred to more favorably in the media.

Company	Overall Sentiment
Health In Tech	Very Positive
OptimizeRx	Positive

Health In Tech presently has a consensus price target of $3.50, suggesting a potential upside of 301.79%. OptimizeRx has a consensus price target of $11.43, suggesting a potential upside of 56.77%. Given Health In Tech's stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Summary

OptimizeRx beats Health In Tech on 10 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

85.0% of Health Catalyst shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Health In Tech has a net margin of 0.00% compared to Health Catalyst's net margin of -90.61%. Health In Tech's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Health In Tech	N/A	N/A	N/A

Health Catalyst presently has a consensus target price of $2.45, suggesting a potential upside of 38.03%. Health In Tech has a consensus target price of $3.50, suggesting a potential upside of 301.79%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Health Catalyst has a beta of 1.53, suggesting that its stock price is 53% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.72, suggesting that its stock price is 172% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than Health Catalyst. Health In Tech is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.43	-$177.97M	-$3.68	N/A
Health In Tech	$32.83M	1.74	-$4.59M	-$0.07	N/A

In the previous week, Health Catalyst had 7 more articles in the media than Health In Tech. MarketBeat recorded 7 mentions for Health Catalyst and 0 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.84 beat Health Catalyst's score of 0.87 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
Health Catalyst	Positive
Health In Tech	Very Positive

Summary

Health In Tech beats Health Catalyst on 12 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Definitive Healthcare?

Health In Tech (NASDAQ:HIT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Health In Tech has a beta of 2.72, indicating that its stock price is 172% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

Health In Tech presently has a consensus price target of $3.50, suggesting a potential upside of 301.79%. Definitive Healthcare has a consensus price target of $1.47, suggesting a potential upside of 53.27%. Given Health In Tech's stronger consensus rating and higher possible upside, equities analysts plainly believe Health In Tech is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

Health In Tech has higher earnings, but lower revenue than Definitive Healthcare. Health In Tech is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.74	-$4.59M	-$0.07	N/A
Definitive Healthcare	$241.52M	0.42	-$138.93M	-$1.60	N/A

Health In Tech has a net margin of 0.00% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Definitive Healthcare	-72.28%	3.55%	1.63%

98.7% of Definitive Healthcare shares are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Definitive Healthcare had 2 more articles in the media than Health In Tech. MarketBeat recorded 2 mentions for Definitive Healthcare and 0 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.84 beat Definitive Healthcare's score of 0.12 indicating that Health In Tech is being referred to more favorably in the media.

Company	Overall Sentiment
Health In Tech	Very Positive
Definitive Healthcare	Neutral

Summary

Health In Tech beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

How does Health In Tech compare to CareCloud?

CareCloud (NASDAQ:CCLD) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

CareCloud has a net margin of 6.21% compared to Health In Tech's net margin of 0.00%. CareCloud's return on equity of 27.07% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
Health In Tech	N/A	N/A	N/A

10.2% of CareCloud shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 77.7% of Health In Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.77	$10.80M	$0.07	31.00
Health In Tech	$32.83M	1.74	-$4.59M	-$0.07	N/A

In the previous week, Health In Tech's average media sentiment score of 1.84 beat CareCloud's score of 1.36 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
CareCloud	Positive
Health In Tech	Very Positive

CareCloud presently has a consensus target price of $3.25, suggesting a potential upside of 49.77%. Health In Tech has a consensus target price of $3.50, suggesting a potential upside of 301.79%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

CareCloud has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.72, meaning that its stock price is 172% more volatile than the broader market.

Summary

CareCloud beats Health In Tech on 8 of the 15 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$57.09M	$1.72B	$7.24B	$13.19B
Dividend Yield	N/A	4.71%	2.57%	12.81%
P/E Ratio	-12.44	20.07	274.93	25.38
Price / Sales	1.74	89.94	646.01	89.45
Price / Cash	N/A	31.60	76.25	51.42
Price / Book	N/A	6.14	10.46	6.33
Net Income	-$4.59M	-$18.66M	$3.49B	$358.33M
7 Day Performance	-3.82%	1.79%	0.59%	1.12%
1 Month Performance	-14.60%	1.77%	-1.74%	-2.39%
1 Year Performance	-75.74%	-14.53%	18.13%	5.35%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	3.0748 of 5 stars	$0.87 +7.5%	$3.50 +301.8%	-75.7%	$57.09M	$32.83M	N/A	91	Positive News Gap Up
AMWL American Well	2.5099 of 5 stars	$13.02 +1.8%	$9.50 -27.0%	+110.2%	$215.18M	$249.32M	N/A	1,040	News Coverage
OPRX OptimizeRx	3.9592 of 5 stars	$7.29 +1.5%	$11.43 +56.8%	-59.9%	$137.31M	$109.43M	31.70	100	News Coverage
HCAT Health Catalyst	4.3791 of 5 stars	$1.70 -1.7%	$2.45 +44.1%	-38.6%	$127.94M	$311.14M	N/A	1,200	News Coverage Insider Trade
DH Definitive Healthcare	2.9921 of 5 stars	$1.05 +1.9%	$1.47 +40.1%	-77.2%	$112.08M	$241.52M	N/A	970	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

How does Health In Tech compare to American Well?

Summary

How does Health In Tech compare to OptimizeRx?

Summary

How does Health In Tech compare to Health Catalyst?

Summary

How does Health In Tech compare to Definitive Healthcare?

Summary

How does Health In Tech compare to CareCloud?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

How does Health In Tech compare to American Well?

Do analysts rate HIT or AMWL?

Which has stronger earnings & valuation, HIT or AMWL?

Is HIT or AMWL more profitable?

Do insiders and institutionals have more ownership in HIT or AMWL?

Does the media prefer HIT or AMWL?

Which has more risk & volatility, HIT or AMWL?

Summary

How does Health In Tech compare to OptimizeRx?

Do insiders & institutionals believe in HIT or OPRX?

Is HIT or OPRX more profitable?

Which has higher earnings & valuation, HIT or OPRX?

Which has more risk and volatility, HIT or OPRX?

Does the media prefer HIT or OPRX?

Do analysts recommend HIT or OPRX?

Summary

How does Health In Tech compare to Health Catalyst?

Do insiders and institutionals hold more shares of HCAT or HIT?

Is HCAT or HIT more profitable?

Do analysts recommend HCAT or HIT?

Which has more risk & volatility, HCAT or HIT?

Which has better earnings & valuation, HCAT or HIT?

Does the media refer more to HCAT or HIT?

Summary

How does Health In Tech compare to Definitive Healthcare?

Which has more volatility and risk, HIT or DH?

Do analysts prefer HIT or DH?

Which has preferable earnings & valuation, HIT or DH?

Is HIT or DH more profitable?

Do insiders & institutionals believe in HIT or DH?

Does the media prefer HIT or DH?

Summary

How does Health In Tech compare to CareCloud?

Is CCLD or HIT more profitable?

Do insiders and institutionals hold more shares of CCLD or HIT?

Which has higher earnings & valuation, CCLD or HIT?

Does the media favor CCLD or HIT?

Do analysts rate CCLD or HIT?

Which has more volatility & risk, CCLD or HIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools